Forbes May 28, 2019
Bruce Japsen

Speculation that Centene will abort its merger with WellCare Health Plans and submit to a takeover by Humana may be subsiding among big institutional investors who remain supportive of the deal.

Reports last week that a small shareholder, Third Point LLC, wants Centene “to consider selling itself” before buying WellCare aren’t going to be enough to change Centene management’s mind. Centene and WellCare last week scheduled a June 24 vote on the merger and say they aren’t backing away from the deal.

Meanwhile, there’s yet to be a big institutional shareholder that has come out against the Centene-WellCare deal. Third Point holds about 1.5% of Centene’s shares and is reportedly buying shares to increase its stake. Third point has no...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Medicaid, Medicare Advantage, Mergers & Acquisitions / JV, Payer, Trends
Thought Inflation Was Bad? Health Insurance Premiums Are Rising Even Faster
What does Trump's new price transparency order mean for insurers?
Providence COO hopeful 2025 will be a 'reset' year with payers
Do US commercial payers consider HTA and economic evidence when making coverage decisions?
The pharmacy change 'key to your future existence as a health plan'

Share This Article